Betta Pharmaceuticals Co., Ltd. (SHE:300558)

Betta Pharmaceuticals Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Market Capitalization	30,204	22,569	21,573	20,525	33,154	44,361
Market Cap Growth	78.99%	4.62%	5.11%	-38.09%	-25.26%	68.38%
Enterprise Value	32,141	24,170	23,045	20,899	31,905	43,858
Last Close Price	71.79	53.76	51.15	48.82	78.66	105.47
PE Ratio	95.55	56.06	61.99	141.14	86.55	73.16
Forward PE	38.39	29.63	42.25	65.91	49.20	99.01
PS Ratio	9.67	7.80	8.78	8.64	14.76	23.72
PB Ratio	5.32	3.98	4.03	4.14	7.08	10.70
P/TBV Ratio	12.90	9.47	7.45	6.38	11.18	14.20
P/FCF Ratio	388.48	270.04	-	-	-	-
P/OCF Ratio	36.20	24.77	23.60	66.91	62.96	68.67
PEG Ratio	-	3.08	3.08	3.08	3.08	3.08
EV/Sales Ratio	10.29	8.36	9.38	8.79	14.21	23.45
EV/EBITDA Ratio	33.96	28.60	39.86	46.08	61.61	76.95
EV/EBIT Ratio	68.24	50.68	82.34	100.98	91.48	105.74
EV/FCF Ratio	413.38	289.20	-	-	-	-
Debt / Equity Ratio	0.43	0.42	0.45	0.21	0.00	0.00
Debt / EBITDA Ratio	2.56	2.82	4.17	2.27	0.02	0.00
Debt / FCF Ratio	31.26	28.67	-	-	-	-
Asset Turnover	0.34	0.31	0.29	0.34	0.39	0.40
Inventory Turnover	1.89	1.74	1.16	0.81	0.72	0.86
Quick Ratio	0.45	0.38	0.58	0.59	1.36	3.64
Current Ratio	0.77	0.66	0.85	0.82	1.86	4.22
Return on Equity (ROE)	5.37%	7.03%	6.47%	2.59%	8.60%	18.18%
Return on Assets (ROA)	3.22%	3.23%	2.05%	1.82%	3.79%	5.54%
Return on Capital (ROIC)	3.68%	3.76%	2.54%	2.42%	4.93%	7.14%
Return on Capital Employed (ROCE)	6.30%	6.40%	3.80%	3.60%	6.50%	8.70%
Earnings Yield	1.05%	1.78%	1.61%	0.71%	1.16%	1.37%
FCF Yield	0.26%	0.37%	-0.84%	-3.43%	-0.70%	-0.09%
Dividend Yield	0.27%	0.37%	0.33%	0.14%	0.32%	0.29%
Payout Ratio	26.48%	37.48%	31.69%	95.94%	35.93%	19.74%
Buyback Yield / Dilution	-0.77%	-0.01%	-0.72%	0.02%	-2.32%	-1.09%
Total Shareholder Return	-0.50%	0.37%	-0.39%	0.16%	-2.00%	-0.80%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.